parkinson-disease

Documents about parkinson-disease

• Optimizing Protein Patterns for Skeletal Muscle Preservation and Sleep in the Medical Management of Parkinson Disease#824872ClinicalTrials.gov
• Walking and Thinking - Brain Activity During Complex Walking in Aging and Parkinson's Disease#831853ClinicalTrials.gov
• A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's Disease#832546ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes#833738ClinicalTrials.gov
• Learning Potential of Patients With Parkinson's Disease After Two Weeks of Targeted Touchscreen Training#850287ClinicalTrials.gov
• Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy Subjects#856414ClinicalTrials.gov
• Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202#861451ClinicalTrials.gov
• Tele-Rehabilitation Intervention in Community-Based Healthcare for Patients With Parkinson's Disease (DHEAL-COM-PD)#862571ClinicalTrials.gov
• Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion#811380ClinicalTrials.gov
• NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)#813825ClinicalTrials.gov
• Association of peripheral and CSF zinc levels with Parkinson's disease: A systematic review and meta-analysis#5269Europe PMC
• Diagnostic Potential of Combined Skin Morphometric Analysis and Salivary Alpha-Synuclein Oligomers in Parkinson's Disease#120143Europe PMC
• Assessing Naturalistic Communication in Parkinson’s Disease: A Passive Audio Capture Study#186601OSF
• US-UK Pricing Comparisons of Parkinson’s Disease Therapies#305976ScholarlyCommons at Penn
• Socio-Occupational Functioning after Subthalamic Deep Brain Stimulation in Parkinson's Disease#322676IRIS
• The effects of nicotine on Parkinson's disease: A systematic review and meta-analysis of experimental evidence#676271Europe PMC
• Association Between Fibrinogen-to-albumin Ratio and Delirium After Deep Brain Stimulation Surgery in Parkinson's Disease#800216ClinicalTrials.gov
• STEM-PD Open Label Extension (OLE)#800438ClinicalTrials.gov
• Single-center Pathophysiological Study of the Role of Inflammation, Changes in the Intestinal Epithelial Barrier and the Intestinal Microbiota in Parkinson's Disease#802499ClinicalTrials.gov
• Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease#832429ClinicalTrials.gov
• Effect of Osteopathic Manipulative Medicine (OMM) on Pulmonary Function and Speech in Parkinson's Disease#846826ClinicalTrials.gov
• The Role of Cerebellar Hyperactivity in Parkinson's Disease#856521ClinicalTrials.gov
• Effect of Vitamin D3 Supplementation on Cardiac Autonomic Nerve Function in Male Parkinson's Disease Patients With Hypovitaminosis D#856658ClinicalTrials.gov
• More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease#830871ClinicalTrials.gov
• Dopaminergic Identity of SH-SY5Y Cells Across Differentiation Protocols in Parkinson's Disease Research: A Systematic Review#205518Europe PMC
• Bio-inspired Solid Lipid Nanoparticles for therapeutic siRNA delivery targeting the LRRK2 G2019S mutation in a Parkinson’s disease cell model.#215983ResearchSpace
• Shared Spectral Parameters Between EEG and Basal Ganglia LFP Distinguish Sleep-Specific Oscillations in Parkinson's Disease#676421Europe PMC
• Corticostriatal glutamate mechanisms underlying beta synchrony and motor deficits via striatal NMDA receptors in Parkinson's disease#676442Europe PMC
• The Effect of Low Frequency STN DBS on Sleep and Vigilance in Parkinson's Disease (PD) Patients#800460ClinicalTrials.gov
• Support needs of people with younger onset Parkinson's disease: An interpretative phenomenological analysis#824158Research Online
• Superior Colliculus Activity in Parkinson Disease: a Potential Marker?#832724ClinicalTrials.gov
• A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients#833795ClinicalTrials.gov
• Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease and Progressive Supranuclear Palsy.#841848ClinicalTrials.gov
• Clinical Relationship Between Vitamin D-mediated Th17 and Treg Cells and Parkinson's Disease#852512ClinicalTrials.gov
• A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients#855651ClinicalTrials.gov
• Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations#856676ClinicalTrials.gov
• Tango for Treatment of Motor and Non-motor Manifestations in Parkinson's Disease.#856760ClinicalTrials.gov
• Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal#861764ClinicalTrials.gov
• Gait asymmetry in Parkinson's disease - a systematic review and meta-analysis (AsymmGait-Parkinson study)#5518Europe PMC
• Parkinson-PEST: protocol for a case-control study on environmental risk factors and Parkinson's disease.#340671NCBI PubMed Central
• Thoracic Spinal Cord Stimulation as a Symptomatic Treatment for Advanced Parkinson's Disease#833446ClinicalTrials.gov
• ANAVEX2-73 Study in Parkinson's Disease Dementia#850469ClinicalTrials.gov
• tDCS of the Primary Motor Cortex to Improve Implicit Motor Sequence Learning in Parkinson's Disease#805399ClinicalTrials.gov
• Amorçage rythmique et production de la parole dans la maladie de Parkinson#475997HAL (France)
• Integrating Eye Tracking and Inertial Sensing for Enhanced Freezing of Gait Detection in Parkinson's Disease#5577Europe PMC
• Cortically Mediated Muscle Responses to Balance Perturbations Increase with Perturbation Magnitude in Older Adults with and without Parkinson's Disease#5585Europe PMC
• Molecular neuroimaging of Parkinson's disease: association of motor and non-motor symptoms with synaptic density, dopaminergic and serotonergic systems#120101Europe PMC
• Increased beta-HFO phase-amplitude coupling in the subthalamic nucleus during movement in Parkinson's disease#234998Europe PMC
• Reproductive factors and clinical features of Parkinson's disease#288359IRIS
• High-Fidelity Synthetic Dataset for Parkinson's Disease Detection#347372Figshare